KiSS1 treatment of pancreatic adenocarcinoma

KiSS1 治疗胰腺癌

• 批准号: 8332910
• 负责人: Lacey R McNally
• 金额: $ 24.15万
• 依托单位: UNIVERSITY OF LOUISVILLE
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-21 至 2014-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8332910
• 关键词: Address; Adenoviruses; Animal Model; Animals; Apoptosis; Biological Models; Bioluminescence; Blood; Breast Melanoma; Cancer Etiology; Cancer Patient; Cells; Cessation of life; Cherry - dietary; Chronic Disease; Clinical; Clinical Trials; Combination Drug Therapy; Cytostatics; Cytotoxic Chemotherapy; Data; Diagnosis; Disease; Early treatment; Enzyme-Linked Immunosorbent Assay; Evaluation; Failure; Future; Goals; Grant; Growth; Hematoxylin and Eosin Staining Method; Hepatic; Histology; Hour; Human; Image; Immunohistochemistry; Implant; In Situ Nick-End Labeling; In Vitro; Infection; Injection of therapeutic agent; Instruction; Investigation; Label; Liver; Luciferases; Lung; Malignant Neoplasms; Malignant neoplasm of ovary; Malignant neoplasm of pancreas; Measures; Messenger RNA; Metastatic Lesion; Metastatic Neoplasm to the Liver; Metastatic Neoplasm to the Lung; Metastatic Pancreatic Adenocarcinoma; Methods; Modeling; Monitor; Morphology; Mus; Neoplasm Metastasis; Organ; Pancreas; Pancreatic Adenocarcinoma; Patients; Pharmaceutical Preparations; Plasmids; Preparation; Primary Neoplasm; Principal Investigator; Progress Reports; Protein Analysis; Proteins; Proto-Oncogene Proteins c-akt; Publishing; Research; Respiratory Diaphragm; Route; SCID Mice; Sampling; Signal Transduction; Staging; Subgroup; Survival Rate; System; Testing; Therapeutic; Therapeutic Agents; Time; Tissues; Transfection; Treatment Efficacy; United States; Update; Viral; Virus; Western Blotting; Xenograft Model; Xenograft procedure; base; cancer cell; chemotherapeutic agent; chemotherapy; conditionally replicative adenovirus; cytotoxic; design; fluorescence imaging; gene therapy; implantation; improved; in vivo; in vivo Model; mouse model; neoplastic cell; novel therapeutic intervention; p65; pancreas xenograft; pancreatic cancer cells; pancreatic neoplasm; prevent; programs; research study; response; restoration; tumor; tumor growth; tumor xenograft